Abingdon Health PLC
ABDX.L operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. ABDX.L is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and is headquartered in the United Kingdom. It is primarily listed on the London Stock Exchange under the ticker ABDX.L. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ABDX.L is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and is headquartered in the United Kingdom. It is primarily listed on the London Stock Exchange under the ticker ABDX.L. Specific details regarding operating segments and geographic revenue mix are not available.
ABDX.L's capital structure is characterized by a current ratio of 1.76, indicating a moderate level of liquidity, and a debt-to-equity ratio of 0.19, suggesting a relatively low reliance on debt financing. The company holds GBP 1.92 million in cash and equivalents, which is a significant portion of its total assets of GBP 9.31 million. However, the company reported negative operating and free cash flows of GBP -3.18 million and GBP -3.15 million, respectively, indicating a cash outflow from operations.
Profitability metrics for ABDX.L are concerning, with a return on equity of -0.6443 and a return on assets of -0.3667, both significantly below the industry norms. The company reported a net loss of GBP -3.42 million, and an operating loss of GBP -3.51 million, which is a clear indicator of financial distress. These figures suggest that the company is not generating sufficient returns to cover its costs and is underperforming relative to its industry peers.
The company's revenue is concentrated in the healthcare services and equipment sector, with no disclosed geographic diversification. This concentration may expose the company to specific market risks, particularly in the UK where it is listed. The lack of geographic diversification could limit its ability to mitigate risks associated with regional economic downturns or regulatory changes.
Looking at the growth trajectory, ABDX.L is currently experiencing a decline in profitability, as evidenced by its negative operating and net income. The company's future growth is uncertain, and there are no disclosed plans for expansion or new product development. The lack of positive growth indicators, combined with the current financial losses, suggests that the company may need to implement significant cost-cutting measures or find new revenue streams to improve its financial position.
The risk assessment for ABDX.L indicates a low level of liquidity and dilution risk. However, the company's negative cash flows and operating losses pose a significant financial risk. The absence of immediate filing-based liquidity or dilution flags is a positive sign, but the company's financial performance suggests that it may need to seek additional financing in the near future. The dilution potential is currently low, but this could change if the company needs to raise capital through equity issuance.
Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial performance has been declining, and there are no disclosed plans to address this issue. The lack of positive developments in the company's operations or financial strategy is a concern for investors and stakeholders.
- ABDX.L is experiencing significant financial losses, with a net loss of GBP -3.42 million and an operating loss of GBP -3.51 million.
- The company's liquidity is moderate, with a current ratio of 1.76 and GBP 1.92 million in cash and equivalents.
- Profitability metrics are poor, with a return on equity of -0.6443 and a return on assets of -0.3667.
- The company's revenue is concentrated in the healthcare services and equipment sector, with no geographic diversification.
- The company's growth trajectory is uncertain, and there are no disclosed plans for expansion or new product development.
- The risk assessment indicates a low level of liquidity and dilution risk, but the company's financial performance suggests a need for additional financing.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,00 |
| Revenue | —no estimate | —no estimate | 15,5M GBP |
| Operating income | —no estimate | —no estimate | -1,1M GBP |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ABDX.L Market data — financials · 2026-05-27
- Abingdon Health PLC Market data — analyst estimates · 2026-05-27